An observational study in Patients Undergoing Anaesthesia Induction, sponsored by Kliniken Essen-Mitte. Recruiting at 1 site in Germany. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-15.
Sponsored by Kliniken Essen-Mitte · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The idea of that project is to characterize the hemodynamic changes of a daily used clinical intervention (induction of anesthesia) in a highly controlled environment by two hemodynamic monitoring devices. The aim is an advanced hemodynamic profiling of this intervention and additionally screen for changes in flow patterns in an exploratory fashion.
Both devices complement one another in their hemodynamic profiling ability. One device is a continuous monitoring with instant traceable changes and the other an intermittent point-of-care ultrasound/echocardiography device with advanced possibilities for differential diagnostics.
A second purpose is to test the possibility to implement advanced echocardiography in a point-of-care approach during anaesthesia induction and evaluate the time and quality of a comprehensive analysis by a not-certified anaesthetists with an echocardiography device with features of artificial intelligence versus a certified expert.
Mortality after surgery is still high and high-risk procedures are associated to high postoperative complication rates. For hemodynamic monitoring, a meta-analysis showed a reduction in mortality and especially for the esophageal Doppler a reduction in postoperative complications. However, the effects reducing mortality and morbidity have to be considered as low. Probably, this is the reason why daily clinical implementation rates of hemodynamic monitoring are low, too.
However, hemodynamic studies only focus on intraoperative optimization, but recent publications suggested that taking preoperative individual hemodynamic values for arterial blood pressure and cardiac index as targets for optimization provides advanced therapeutic options. Lastly, both studies do not provide data about the preoperative values and their changes during the induction of anesthesia.
Our own data confirm that the induction of anesthesia, the establishment of a working epidural and the surgical incision of the abdomen leads to decreased cardiac index and markers of inotropy in otherwise cardiovascular healthy patients. However, the intervention studies and our own data strongly suggest that starting hemodynamic monitoring after the induction of anesthesia or the surgical incision may foreclose that the clinician can guide the hemodynamic therapy towards individualized goals. Additionally, the corrective treatment in this scenario could be different from just vasopressors.
Nevertheless, in contrast to our own data a recent study showed that hypotension in the post-induction period is primarily associated with a decreased vascular tone due to anesthetic agents, suggesting that the appropriate treatment is vasopressors.
A detailed hemodynamic profiling of non-cardiac patients undergoing high-risk cancer surgery prior, during and after the induction of anaesthesia may provide new insights about the effects of anaesthetic drugs, positive pressure ventilation, and changes of sympathetic tone.
Kliniken Essen-Mitte is the lead sponsor of 18 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with the diagnosis of advanced primary ovarian cancer will be screened prior to cytoreductive surgery in cooperation with the colleagues of gynaecological oncology. If the patients are eligible they will be informed to give consent.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Longitudinal change of heart rate assessed in percentages during the induction of anaesthesia
The heart rate will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Longitudinal change of arterial blood pressure assessed in percentaqes during the induction of anaesthesia
The arterial blood pressures will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Longitudinal change of stroke volume assessed in percentaqes during the induction of anaesthesia
The stroke volume will be monitored continuously to detect any change of it during the induction of anaesthesia. The change will be described in percentages.
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Longitudinal change of myocardial strain imaging assessed by transthoracic echocardiography during the induction of anaesthesia
The echocardiographic feature of strain imaging for the analysis of contractile performance of the myocardium will be monitored prior to induction and after induction of anaesthesia to detect any changes
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes in percentages in a comprehensive echocardiographic assessment of the right ventricle and atrium
The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes of the left ventricular and atrial volume in percentages assessed by a transthoracic echocardiography
The echocardiographic parameter will be monitored prior to induction and after induction of anaesthesia to detect any changes.
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes of the left ventricular systolic and diastolic function in percentages assessed by a transthoracic echocardiography
The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes of function of the cardiac valves assessed by a transthoracic echocardiography
The echocardiographic features will be monitored prior to induction and after induction of anaesthesia to detect any changes of the cardiac valve functions like increase of regurgitation
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes in percentage of the cardiocirculatory flow in an advanced hemodynamic monitoring device based on a pulse-contour methodology in a continuous fashion during induction of anaesthesia
The haemodynamic features will be monitored prior to the start of induction up to the end of induction of anaesthesia to detect any changes
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Changes of flow profiles of the splanchnic vessels as well as peripheral arteries determined by ultrasound
The ultrasound features will be monitored prior to induction and after induction of anaesthesia to detect any changes
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Mean systemic filling pressure (MSFP)
The MSFP will be determined based on the stop-flow-methodology to determine additionally venous return characteristics
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Baroreceptor sensitivity (BRS)
BRS will be determined to analyse the impact of drugs of anaesthesia induction on the vegetative nervous system. The assessment is based on invasive measurement of the arterial blood pressure in combination with the electrocardiogram
Time frame: Time from the start of anaesthesiological monitoring up to start of surgical measures, up to four hours
Examination times of the echocardiographic assessment by a not-certified expert
The characteristics of an echocardiographic assessment will be analysed to examine the feasibility within clinical routine and the results will be compared to the results of a certified echocardiographic expert
Time frame: Time from the start of anaesthesiological monitoring up to the start of anaesthesia induction, up to four hours
Implementation rates in percentages of the echocardiographic assessment by a not-certified expert during clinical care
The characteristics of an echocardiographic assessment will be analysed to examine the feasibility within clinical routine and the results will be compared to the results of a certified echocardiographic expert
Time frame: Time from the start of anaesthesiological monitoring up to the start of anaesthesia induction, up to four hours
Number of missed diagnositics of the echocardiographic assessment by a not-certified expert vs. an assessment by a certified examiner
The characteristics of an echocardiographic assessment will be analysed to examine the feasibility within clinical routine and the results will be compared to the results of a certified echocardiographic expert
Time frame: Time from the start of anaesthesiological monitoring up to the start of anaesthesia induction, up to four hours
Incidence and description of postoperative complications
The complications will be graded according to the "Clavien-Dindo" classification from one to five with one being a minor complication and five being death
Time frame: Time of hospital stay, i.d. from the time of surgery up to discharge from the hospital, up to 30 days after surgery
Incidence and description of postoperative organ dysfunctions
The incidence of organ dysfunctions will be based on laboratory results and or pathophysiological features like delayed bowel opening after surgery
Time frame: Time of hospital stay, i.d. from the time of surgery up to discharge from the hospital, up to 30 days after surgery
Plan to share: No
Started Jan 2025 (actual). Primary completion is estimated for Dec 2025, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kliniken Essen-Mitte